Abstract

BackgroundNon-ischemic cardiomyopathy (NICM) is a heterogeneous disease, and its prognosis varies. Although late gadolinium enhancement (LGE)-cardiovascular magnetic resonance (CMR) demonstrates a linear pattern in the mid-wall of the septum or multiple LGE lesions in patients with NICM, the therapeutic response and prognosis of multiple LGE lesions have not been elucidated. This study aimed to investigate the frequency of left ventricular (LV) reverse remodeling (LVRR) and prognosis in patients with NICM who have multiple LGE lesions.Methods This single-center retrospective study included 101 consecutive patients with NICM who were divided into 3 groups according to LGE-CMR results: patients without LGE (no LGE group = 48 patients), patients with a typical mid-wall LGE pattern (n = 29 patients), and patients with multiple LGE lesions (n = 24 patients). LVRR was defined as an increase in LV ejection fraction (LVEF) ≥ 10 % and a final value of LVEF > 35 %, which was accompanied by a decrease in LV end-systolic volume ≥ 15 % at 12-month follow-up using echocardiography. The frequency of composite cardiac events, defined as sudden cardiac death (SCD), aborted SCD (non-fatal ventricular fibrillation, sustained ventricular tachycardia, or adequate implantable cardioverter-defibrillator therapies), and heart failure death or hospitalization for worsening heart failure, were summarized and compared between the groups.ResultsAmong the 3 groups, the frequency of LVRR was significantly lower in the multiple lesions group than in the no LGE and mid-wall groups (no LGE vs. mid-wall vs. multiple lesions: 49 % vs. 52 % vs. 19 %, p = 0.03). There were 24 composite cardiac events among the patients: 2 in patients without LGE (hospitalization for worsening heart failure; 2), 7 in patients of the mid-wall group (SCD; 1, aborted SCD; 1 and hospitalization for worsening heart failure; 5), and 15 in patients of the multiple lesions group (SCD; 1, aborted SCD; 8 and hospitalization for worsening heart failure; 6). The multiple LGE lesions was an independent predictor of composite cardiac events (hazard ratio: 11.40 [95 % confidence intervals: 1.49−92.01], p = 0.020).ConclusionsPatients with multiple LGE lesions have a higher risk of cardiac events and poorer LVRR. The LGE pattern may be useful for an improved risk stratification in patients with NICM.

Highlights

  • Non-ischemic cardiomyopathy (NICM) is a heterogeneous disease, and its prognosis varies

  • This study aimed to describe the frequency of LV reverse remodeling (LVRR) and prognosis in patients with NICM who have multiple late gadolinium enhancement (LGE) lesions

  • There were no significant differences among the groups with regard to gender, age, hypertension, diabetes, Estimated glomerular filtration rate (eGFR), blood pressure, atrial fibrillation, QRS duration, medications at the beginning of the study, and LV end-diastolic volume (LVEDV)

Read more

Summary

Introduction

Non-ischemic cardiomyopathy (NICM) is a heterogeneous disease, and its prognosis varies. This study aimed to investigate the frequency of left ventricular (LV) reverse remodeling (LVRR) and prognosis in patients with NICM who have multiple LGE lesions. Non-ischemic cardiomyopathy (NICM) is characterized by a reduction in left ventricular (LV) systolic function in the absence of significant coronary artery disease. NICM with LV enlargement due to remodeling is called non-ischemic dilated cardiomyopathy (DCM) [1, 2]. NICM is a heterogeneous disease, and its response to therapy is varied. The evaluation of myocardial fibrosis is the key mechanism for distinguishing among phenotypes and predicting therapeutic reactivity in patients with NICM [4]. An endomyocardial biopsy is required for a conclusive diagnosis; the diagnostic value of endomyocardial biopsy is limited, and nonspecific myocardial fibrosis was observed in approximately 80 % of patients who underwent endomyocardial biopsy [5]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call